Genmab | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Almirall EUR 377.1M 47.69M 2024-12
Amarin USD 156.94M 58.98M 2024-09
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 4.02B 2.18B 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Demant 1.11B 64M 2024-12
Exelixis USD 183.75M 33.62M 2025-04
Fresenius Medical Care EUR 1.07B 109M 2025-03
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 1.62B 8.24B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
GN Store Nord DKK 787M 99M 2025-03
GRIFOLS EUR 752.82M 226.96M 2025-03
Hikma Pharmaceutical USD 0 1000K 2024-06
Insmed USD 403.25M 151.78M 2025-03
Lonza CHF 1.11B 286M 2024-12
Merck EUR 2.15B 1.01B 2024-12
Novartis USD 8.87B 4.74B 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
UCB EUR 1.57B 1.14B 2024-12



Genmab Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.